Exhar Formulations Private Limited
About Exhar Formulations Private Limited
Data last updated:
Exhar Formulations Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51511DL2007PTC162025. Its GSTIN is 07AABCE7637H1ZK (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Rajeev Sinha Kumar and Anandam Sinha.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No 364 Third Floor Vardhman Crown Mall, Plot No 2 Sector 19 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2020, the company reported a revenue of ₹4.84 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹14.32 Lakh (net margin 3%) and EBITDA of ₹14.14 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹30 Lakh on record. Court records list 6 cases involving the company, including 6 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Exhar Formulations Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 364 Third Floor Vardhman Crown Mall, Plot No 2 Sector 19 Dwarka, New Delhi, Delhi, India – 110075
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Exhar Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Exhar Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Exhar Formulations Private Limited, buy the company report.
Financials of Exhar Formulations Private Limited
FY 2023 filings availableExhar Formulations Private Limited reported revenue of ₹4.84 Cr (up 21% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 21% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Exhar Formulations Private Limited, buy the company report.
Board of directors of Exhar Formulations Private Limited
Exhar Formulations has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Sinha Also directs: Excellent Nutraceuticals Private Limited | Additional Director | 01 Jul 2009 | 17 Years 3 Months | Current |
| Meeta Sinha | Additional Director | 01 Jul 2009 | 17 Years 3 Months | Current |
| Binay Kumar Also directs: Excellent Nutraceuticals Private Limited | Additional Director | 01 Jul 2009 | 17 Years 3 Months | Current |
| Rajiv Kumar | Additional Director | 01 Jul 2009 | 17 Years 3 Months | Current |
| Rajeev Sinha Kumar Also directs: Excellent Nutraceuticals Private Limited | Director | 13 Apr 2007 | 19 Years 6 Months | Current |
| Anandam Sinha Also directs: Excellent Nutraceuticals Private Limited | Director | 13 Apr 2007 | 19 Years 6 Months | Current |
Peer comparison
Exhar Formulations Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allen's India Ltd. | ₹4.86 Cr (FY 2024) | 1.0% | Kolkata, West Bengal, India | |||
| Uniphar Biotech Private Limited | ₹4.85 Cr (FY 2024) | -9.0% | Chandigarh, India | |||
| Aarier Pharma Private Limited | ₹4.85 Cr (FY 2025) | 109.0% | Mumbai, Maharashtra, India | |||
| Villmed Laboratories Private Limited | ₹4.85 Cr (FY 2024) | 112.0% | Selaqui, Uttarakhand, India | |||
| Transcure Therapeutics Private Limited | ₹4.85 Cr (FY 2025) | 17.0% | Ludhiana, Punjab, India | |||
| Exhar Formulations Private Limitedthis company | ₹4.84 Cr (FY 2020) | ₹14.32 Lakh | 3% | 21.0% | 9 | New Delhi, Delhi, India |
| Sycon Healthcare Private Limited | ₹4.83 Cr (FY 2024) | 0.0% | Shahabad Markanda, Haryana, India | |||
| Won Healthcare Private Limited | ₹4.83 Cr (FY 2025) | 24.0% | Muzaffarnagar, Uttar Pradesh, India | |||
| VRD Pharmaceuticals and Surgicals Private Limited | ₹4.83 Cr (FY 2024) | -20.0% | Dibrugarh, Assam, India |
To see the full peer comparison of Exhar Formulations Private Limited, buy the company report.
Auditor
Exhar Formulations Private Limited is audited by HARESH MISHRA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARESH MISHRA & ASSOCIATES | FY 2018 | 024716N |
Shareholding
The shareholding of Exhar Formulations Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Exhar Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jul 2019 | 100280785 | Others | ₹30 Lakh | Satisfied |
To see the full charge records of Exhar Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Exhar Formulations Private Limited has 6 court cases on record: 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 0 |
Cases on record (4 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Court case (TM) | Filed against the company by Ms Excellar Healthcare Pvt. Ltd | Disposed |
| District court, West, Delhi | Court case (TM) | Filed against the company by Ms Excell Formulations Pvt. Ltd | Disposed |
| District court, New Delhi, Delhi | Court case (TM) | Filed against the company by Ms Excel Formulations Pvt Ltd | Disposed |
| District court, New Delhi, Delhi | Court case (TM) | Filed against the company by Ms Excellar Heathcare P.Ltd. | Disposed |
To see the full case history of Exhar Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exhar Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Exhar Formulations Private Limited has a workforce of 9 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Exhar Formulations has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCE7637H1ZK | Delhi | Active | 01 Jul 2017 |
| 10AABCE7637H1ZX | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Exhar Formulations Private Limited, buy the company report.
Recent activity
Exhar Formulations Private Limited has 6 board changes on record since 2007: 6 appointments. The latest: Binay Kumar was appointed as Additional Director on 01 Jul 2009.
Frequently asked questions
Exhar Formulations is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 April 2007 (19+ years old) and is registered under CIN U51511DL2007PTC162025.
Exhar Formulations has 6 current directors:
- Rakesh Sinha - Additional Director
- Meeta Sinha - Additional Director
- Binay Kumar - Additional Director
- Rajiv Kumar - Additional Director
- Rajeev Sinha Kumar - Director
- Anandam Sinha - Director
The latest financial statements of Exhar Formulations on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Exhar Formulations is 07AABCE7637H1ZK, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AABCE7637H1ZX (Bihar).
The CIN (Corporate Identification Number) of Exhar Formulations is U51511DL2007PTC162025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exhar Formulations has 6 court cases on record: 6 filed against it.
Exhar Formulations was incorporated on 13 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Exhar Formulations by revenue are Allen's India Ltd, Uniphar Biotech Private Limited, Aarier Pharma Private Limited, Villmed Laboratories Private Limited, Transcure Therapeutics Private Limited and 3 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Binay Kumar was appointed as Additional Director on 01 Jul 2009. Meeta Sinha was appointed as Additional Director on 01 Jul 2009. Rajiv Kumar was appointed as Additional Director on 01 Jul 2009. Exhar Formulations has 6 board changes on record in total.
The registered office of Exhar Formulations is at Shop No 364 Third Floor Vardhman Crown Mall, Plot No 2 Sector 19 Dwarka, New Delhi, Delhi, India – 110075.
Exhar Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.